Meridian Bioscience, Inc. (VIVO) Tops Q4 EPS by 2c
Tweet
Share
E-mailGet Alerts VIVO Hot Sheet
Price: $5.87 +7.71%
Financial Fact:
Selling and marketing: 8.13M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Financial Fact:
Selling and marketing: 8.13M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Meridian Bioscience, Inc. (NASDAQ: VIVO) reported Q4 EPS of $0.21, $0.02 better than the analyst estimate of $0.19. Revenue for the quarter came in at $43.7 million versus the consensus estimate of $42.97 million.
For earnings history and earnings-related data on Meridian Bioscience, Inc. (VIVO) click here.
For earnings history and earnings-related data on Meridian Bioscience, Inc. (VIVO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- JPMorgan Starts ICICI Prudential Asset Management (ICICIAMC:IN) at Overweight
- MP Materials seen largely insulated after China export-control move
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
